Summary Summary Short summary of a recent publication, written by scientific experts.

Antagonism of transient receptor potential vanilloid 4 blocks mechanically-induced myotonia

Takeaway

  • Activation of transient receptor potential vanilloid 4 during muscle contraction in a mouse model plays a key role in triggering myotonia.

Why this matters

  • Existing myotonia therapies have limited tolerability and effectiveness.

    • These data are the first to demonstrate the existence of distinct molecular mechanisms triggering electrically- and mechanically-induced myotonia. Elimination of mechanically-induced myotonia by transient receptor potential vanilloid 4 inhibition represents a novel therapeutic approach.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.

Learn more

Movement Disorders TRPV4 Myotonia congenita Pharmacologic antagonism Transient receptor potential vanilloid 4 Mechanically-induced